The peripheral blood lymphocyte signatures forecast therapeutic efficacy in papillary thyroid cancer patients undergoing radioactive iodine therapy.
APA
Cao J, Sun Y, et al. (2026). The peripheral blood lymphocyte signatures forecast therapeutic efficacy in papillary thyroid cancer patients undergoing radioactive iodine therapy.. Endocrine, 91(1), 53. https://doi.org/10.1007/s12020-025-04520-4
MLA
Cao J, et al.. "The peripheral blood lymphocyte signatures forecast therapeutic efficacy in papillary thyroid cancer patients undergoing radioactive iodine therapy.." Endocrine, vol. 91, no. 1, 2026, pp. 53.
PMID
41627546
같은 제1저자의 인용 많은 논문 (5)
- Based on WGCNA and machine learning studies, SMURF2 drives NSCLC malignant transformation, ferroptosis, and macrophage polarization by ubiquitinating SPP1.
- Engineered exosome nanovesicles for delivery of antibodies to treat inflammatory bowel disease.
- Knowledge, attitudes, and practices of lung cancer patients regarding nutritional management during chemotherapy.
- Disulfiram/Copper Combination as a Potential Therapeutic Approach for Hepatocellular Carcinoma: Targeting the ATF3-Mitochondrial Cell Death Pathway.
- MRI-based clinical-radiomics-habitat model for predicting prognosis of hepatocellular carcinoma patients treated with HAIC.